SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014670
Filing Date
2021-11-04
Accepted
2021-11-04 17:15:57
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20210930x10q.htm   iXBRL 10-Q 2299887
2 EX-31.1 iova-20210930xex31d1.htm EX-31.1 12339
3 EX-31.2 iova-20210930xex31d2.htm EX-31.2 12227
4 EX-32.1 iova-20210930xex32d1.htm EX-32.1 7096
5 EX-32.2 iova-20210930xex32d2.htm EX-32.2 7179
6 GRAPHIC iova-20210930x10q001.jpg GRAPHIC 140070
  Complete submission text file 0001558370-21-014670.txt   9164048

Data Files

Seq Description Document Type Size
7 EX-101.SCH iova-20210930.xsd EX-101.SCH 52727
8 EX-101.CAL iova-20210930_cal.xml EX-101.CAL 52931
9 EX-101.DEF iova-20210930_def.xml EX-101.DEF 213260
10 EX-101.LAB iova-20210930_lab.xml EX-101.LAB 420616
11 EX-101.PRE iova-20210930_pre.xml EX-101.PRE 374066
12 EXTRACTED XBRL INSTANCE DOCUMENT iova-20210930x10q_htm.xml XML 1711635
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 211381146
SIC: 2836 Biological Products, (No Diagnostic Substances)